{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:53:58Z","timestamp":1762955638298},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":88,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The aims of the present study were to analyze the outcomes of pregnancy, after 131I treatment, in patients of reproductive age with Graves\u2019 hyperthyroidism and to investigate the effects, if any, of the 131I treatment on the mothers and newborns. From 2009 to 2014, 257 pregnant female patients with Graves\u2019 hyperthyroidism in the outpatients at the Department of Nuclear Medicine and 166 healthy pregnant women from the Department of Obstetrics at Sun Yat-Sen Memorial Hospital were included in our study. They were divided into a 131I therapy group (n\u00a0=\u00a0130) and an anti-thyroid drug (ATD) group (n\u00a0=\u00a0127) according to their therapy before conception. The neonatal gender, rate of preterm birth, body weight ratio and occurrence of low birth weight [except for higher rates of abortion (odds ratio; OR\u00a0=\u00a02.023) and cesarean delivery (OR\u00a0=\u00a01.552) in patients with Graves\u2019 hyperthyroidism] showed no statistically significant differences from those of the healthy group (P\u00a0&amp;gt;\u00a00.05). The level of intrauterine growth restriction did not differ between the Graves\u2019 hyperthyroidism group and the healthy group (8 vs 2, 3.0% vs 1.2%). The outcomes of pregnancy among the 131I therapy group, ATD group and healthy group also showed no significant differences. Of the patients treated with 131I, no significant differences were observed in the outcomes of their pregnancies, whether they received propylthiouracil (PTU), levothyroxine or no additional drug treatment during pregnancy. Women with hyperthyroidism who were treated with 131I therapy could have normal delivery if they ceased 131I treatment for at least six months prior to conception and if their thyroid function was reasonably controlled and maintained using the medication: anti-thyroid drug and levothyroxine before and during pregnancy.<\/jats:p>","DOI":"10.1093\/jrr\/rrw049","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T01:49:55Z","timestamp":1473731395000},"page":"702-708","source":"Crossref","is-referenced-by-count":9,"title":["Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves\u2019 disease after 131Iodine treatment"],"prefix":"10.1093","volume":"57","author":[{"given":"Li-Hua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Gen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning-Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"2020010903081680800_rrw049C1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid"},{"key":"2020010903081680800_rrw049C2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2265.2004.02152.x","article-title":"Long-term follow-up study of radioiodine treatment of hyperthyroidism","volume":"61","author":"Metso","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020010903081680800_rrw049C3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000357615","article-title":"Pregnancy outcome in hyperthyroidism: a case control study","volume":"77","author":"Aggarawal","year":"2014","journal-title":"Gynecol Obstet Invest"},{"key":"2020010903081680800_rrw049C4","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jc.2012-4233","article-title":"Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort","volume":"98","author":"Mannisto","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020010903081680800_rrw049C5","first-page":"21","article-title":"Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma","volume":"36","author":"Dottorini","year":"1995","journal-title":"J Nucl Med"},{"key":"2020010903081680800_rrw049C6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF03350795","article-title":"Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas","volume":"21","author":"Lin","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020010903081680800_rrw049C7","first-page":"847","article-title":"Iodine-131: optimal therapy for hyperthyroidism in children and adolescents","volume":"20","author":"Freitas","year":"1979","journal-title":"J Nucl Med"},{"key":"2020010903081680800_rrw049C8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1056\/NEJM197501232920401","article-title":"Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism","volume":"292","author":"Safa","year":"1975","journal-title":"N Engl J Med"},{"key":"2020010903081680800_rrw049C9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM197010292831802","article-title":"Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine","volume":"283","author":"Hayek","year":"1970","journal-title":"N Engl J Med"},{"key":"2020010903081680800_rrw049C10","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1210\/jc.2014-1168","article-title":"Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism","volume":"99","author":"Ohrling","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020010903081680800_rrw049C11","first-page":"856","article-title":"Procedure guideline for therapy of thyroid disease with 131iodine","volume":"43","author":"Meier","year":"2002","journal-title":"J Nucl Med"},{"key":"2020010903081680800_rrw049C12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1259\/0007-1285-59-697-45","article-title":"The long-term hazards of the treatment of thyroid cancer with radioiodine","volume":"59","author":"Edmonds","year":"1986","journal-title":"Br J Radiol"},{"key":"2020010903081680800_rrw049C13","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2307\/3578892","article-title":"Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958\u20131987","volume":"137","author":"Thompson","year":"1994","journal-title":"Radiat Res"},{"key":"2020010903081680800_rrw049C14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jcem-69-1-186","article-title":"Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine","volume":"69","author":"Raymond","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020010903081680800_rrw049C15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"2020010903081680800_rrw049C16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020010903081680800_rrw049C17","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/EJE-14-0524","article-title":"Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole\/carbimazole embryopathy","volume":"171","author":"Andersen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2020010903081680800_rrw049C18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman","year":"2012","journal-title":"QJM"},{"key":"2020010903081680800_rrw049C19","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","article-title":"A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves\u2019 patients","volume":"89","author":"Read","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020010903081680800_rrw049C20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198111263052205","article-title":"Current concepts: beta-blockers in pregnancy","volume":"305","author":"Rubin","year":"1981","journal-title":"N Engl J Med"},{"key":"2020010903081680800_rrw049C21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/RLU.0000000000000386","article-title":"Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs","volume":"39","author":"Yoshihara","year":"2014","journal-title":"Clin Nucl Med"},{"key":"2020010903081680800_rrw049C22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/83.15.1072","article-title":"Cancer risk after iodine-131 therapy for hyperthyroidism","volume":"83","author":"Holm","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"2020010903081680800_rrw049C23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1345\/aph.1H535","article-title":"Propylthiouracil versus methimazole in treatment of Graves\u2019 disease during pregnancy","volume":"41","author":"Chattaway","year":"2007","journal-title":"Ann Pharmacother"},{"key":"2020010903081680800_rrw049C24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"2020010903081680800_rrw049C25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.EJ14-0145","article-title":"Management of hyperthyroidism during pregnancy in Asia","volume":"61","author":"Azizi","year":"2014","journal-title":"Endocr J"},{"key":"2020010903081680800_rrw049C26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/thy.2014.0434","article-title":"Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system","volume":"25","author":"Lo","year":"2015","journal-title":"Thyroid"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article\/57\/6\/702\/2605888","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article\/57\/6\/702\/2605888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T08:12:49Z","timestamp":1578557569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/57\/6\/702\/2605888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,12,2]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrw049","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,9]]}}}